Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021)
- PMID: 35929879
- DOI: 10.1080/13543776.2022.2109413
Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021)
Abstract
Introduction: Iron oxide nanoparticles (IONPs) hold the edges of great magnetic properties and fine nanoparticle characteristics, making them an attractive therapeutic agent. In the past seven years, more in-depth investigations were devoted to the intrinsic structure, magnetic properties, and biological effects of IONPs, expanding the range of their therapeutic application scenes.
Areas covered: This review focuses on the development of IONPs for biomedical applications from the angle of the patent literature reported during the period 2015-2021.
Expert opinion: While the magnetic properties of IONPs have been extensively explored, the precise control of IONP behavior through external magnetic fields remains a challenge. Further digging into the biological effects of IONPs will facilitate the development of IONP-based immune therapies. Long-term reliable safety evaluations are of necessity and significance to promote the process of clinical translation.
Keywords: Iron oxide nanoparticles; MRI; drug delivery; theranostics; treatment.
Similar articles
-
Recent advances in iron oxide nanoparticles for brain cancer theranostics: from in vitro to clinical applications.Expert Opin Drug Deliv. 2021 Jul;18(7):949-977. doi: 10.1080/17425247.2021.1888926. Epub 2021 Apr 1. Expert Opin Drug Deliv. 2021. PMID: 33567919 Review.
-
Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration.Life Sci. 2021 Jul 15;277:119625. doi: 10.1016/j.lfs.2021.119625. Epub 2021 May 17. Life Sci. 2021. PMID: 34015288
-
Hepatotoxic and Neurotoxic Potential of Iron Oxide Nanoparticles in Wistar Rats: a Biochemical and Ultrastructural Study.Biol Trace Elem Res. 2022 Aug;200(8):3638-3665. doi: 10.1007/s12011-021-02943-4. Epub 2021 Oct 26. Biol Trace Elem Res. 2022. PMID: 34704196
-
Iron oxide nanoparticle targeting mechanism and its application in tumor magnetic resonance imaging and therapy.Nanomedicine (Lond). 2022 Sep;17(21):1567-1583. doi: 10.2217/nnm-2022-0246. Epub 2022 Dec 2. Nanomedicine (Lond). 2022. PMID: 36458585 Review.
-
Chemical transformation and cytotoxicity of iron oxide nanoparticles (IONPs) accumulated in mitochondria.Talanta. 2023 Jan 1;251:123770. doi: 10.1016/j.talanta.2022.123770. Epub 2022 Aug 5. Talanta. 2023. PMID: 35961081
Cited by
-
Mannose-coated superparamagnetic iron oxide nanozyme for preventing postoperative cognitive dysfunction.Mater Today Bio. 2023 Feb 14;19:100568. doi: 10.1016/j.mtbio.2023.100568. eCollection 2023 Apr. Mater Today Bio. 2023. PMID: 36846307 Free PMC article.
-
Comparative time-dependent proteomics reveal the tolerance of cancer cells to magnetic iron oxide nanoparticles.Regen Biomater. 2024 Jun 4;11:rbae065. doi: 10.1093/rb/rbae065. eCollection 2024. Regen Biomater. 2024. PMID: 38933085 Free PMC article.
-
Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance.Pharmaceutics. 2024 Dec 3;16(12):1549. doi: 10.3390/pharmaceutics16121549. Pharmaceutics. 2024. PMID: 39771528 Free PMC article. Review.
-
Nanotechnology-Based Drug Delivery Systems to Control Bacterial-Biofilm-Associated Lung Infections.Pharmaceutics. 2023 Nov 3;15(11):2582. doi: 10.3390/pharmaceutics15112582. Pharmaceutics. 2023. PMID: 38004561 Free PMC article. Review.
-
Green synthesis an eco-friendly route for the synthesis of iron oxide nanoparticles using aqueous extract of Thevetia peruviana and their biological activities.Sci Rep. 2025 May 26;15(1):18316. doi: 10.1038/s41598-025-02387-z. Sci Rep. 2025. PMID: 40419567 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous